Mangoceuticals, Inc. (NASDAQ: MGRX) announced on December 19, 2024, the acquisition of patent number WO 2023/086647 PCT/US2022/049857, covering mushroom-derived compositions and methods of treatment. This acquisition expands MangoRx's intellectual property portfolio into holistic health and wellness.
The patent encompasses nutraceutical compositions from functional mushrooms like Cordyceps sinensis, Ganoderma lucidum (Reishi), and Hericium erinaceus (Lion's Mane). These formulations are designed to offer benefits such as enhanced immune function, boosted cognitive performance, mood support, and appetite suppression.
This move positions Mangoceuticals in the rapidly expanding global functional mushroom market, which was valued at $32.41 billion in 2024 and is projected to grow to $48.59 billion by 2029, representing an 8.44% compound annual growth rate. The company plans to leverage this patent to research and develop new wellness products, including dietary supplements and functional foods.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.